Ipsen’s Acquisition of Epizyme

Orrick Herrington & Sutcliffe advised Ipsen on the deal. Global biopharmaceutical company Ipsen (Euronext: IPN; ADR: IPSEY) announced its definitive agreement to acquire Epizyme (Nasdaq: EPZM), a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Convergenta’s Investment in CECONOMY

Orrick advised Convergenta Invest GmbH on the deal. Noerr advised CECONOMY. Convergenta Invest GmbH, an investment company of the Media-Markt founding family Kellerhals, announced the acquisition of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

EcoVadis’ $500 Million Fundraising

Jones Day advised EcoVadis on the deal. Orrick advised Princeville Capital. Goodwin Procter represented Astorg. EcoVadis, a leading global sustainability rating firm, announced its $500 million fundraising....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here